MARK OLDENDORF: Open Payments
NPI 1427147800 · LOUDONVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 35 payments from 20 companies in 2025. Trend: 2023 $1,116 · 2024 $1,057 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $177 |
| Exact Sciences Corporation | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| ABBVIE INC. | 2 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Indivior Inc. | 2 | $41 |
| Braeburn Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: Wegovy, REXULTI, The Cologuard Plus Collection Kit, ZEPBOUND, SUBLOCADE, BRIXADI, QULIPTA, GEMTESA.
Industry payments across NY — which companies pay providers there.
